Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)

This study has been completed.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: June 26, 2007
Last updated: February 7, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)